Dynavax (DVAX) Rockets 38% on Sanofi $2-Billion Merger

We precocious published 10 Stocks Lighting Up Market Ahead of Christmas. Dynavax Technologies Corp. (NASDAQ:DVAX) is 1 of the champion performers connected Wednesday.

Dynavax soared by 38.19 percent connected Wednesday to adjacent astatine $15.38 apiece arsenic investors took bosom from quality that it was acceptable to beryllium acquired by Sanofi for $2.2 billion.

In a statement, Dynavax Technologies Corp. (NASDAQ:DVAX) said that it officially entered into an statement with Sanofi for the latter’s acquisition of each its outstanding shares astatine a terms of $15.50 apiece.

The connection terms represents a premium of astir 39 percent implicit its closing terms connected December 23.

The acquisition would augment Sanofi’s beingness successful big immunization, peculiarly with Dynavax Technologies Corp.’s (NASDAQ:DVAX) big hepatitis B vaccine Heplisav-B—currently marketed successful the US and differentiated by its two-dose regimen implicit 1 month, which enables precocious levels of seroprotection faster than different hepatitis B vaccines, which are fixed successful 3 doses implicit six months.

The acquisition besides includes Dynavax Technologies Corp.’s (NASDAQ:DVAX) shingles vaccine campaigner (Z-1018), which is presently successful signifier 1/2 objective development, arsenic good arsenic different vaccine pipeline projects.

“Joining Sanofi volition supply the planetary standard and expertise needed to maximize the interaction of our vaccine portfolio,” said CEO Ryan Spencer.

“We judge Sanofi’s commercialized reach, improvement capabilities, and committedness to evidence-based immunization volition amplify the accidental for Heplisav-B and our innovative pipeline to code important nationalist wellness needs, further advancing our ngo to assistance support the satellite against infectious disease. We are assured that this transaction – and the compelling worth it provides – is successful the champion interests of the Company and its stockholders,” helium added.

While we admit the imaginable of DVAX arsenic an investment, our condemnation lies successful the content that immoderate AI stocks clasp greater committedness for delivering higher returns and person constricted downside risk. If you are looking for an highly inexpensive AI banal that is besides a large beneficiary of Trump tariffs and onshoring, spot our escaped study connected the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double successful 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This nonfiction is primitively published at Insider Monkey.